These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31827600)

  • 1. Changes in circulating microRNA after recumbent isometric yoga practice by patients with myalgic encephalomyelitis/chronic fatigue syndrome: an explorative pilot study.
    Takakura S; Oka T; Sudo N
    Biopsychosoc Med; 2019; 13():29. PubMed ID: 31827600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a recumbent isometric yoga program for patients with severe chronic fatigue syndrome/myalgic encephalomyelitis: A pilot study to assess feasibility and efficacy.
    Oka T; Wakita H; Kimura K
    Biopsychosoc Med; 2017; 11():5. PubMed ID: 28270860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The longitudinal effects of seated isometric yoga on blood biomarkers, autonomic functions, and psychological parameters of patients with chronic fatigue syndrome: a pilot study.
    Oka T; Tanahashi T; Lkhagvasuren B; Yamada Y
    Biopsychosoc Med; 2019; 13():28. PubMed ID: 31709006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in fatigue, autonomic functions, and blood biomarkers due to sitting isometric yoga in patients with chronic fatigue syndrome.
    Oka T; Tanahashi T; Sudo N; Lkhagvasuren B; Yamada Y
    Biopsychosoc Med; 2018; 12():3. PubMed ID: 29643935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isometric yoga improves the fatigue and pain of patients with chronic fatigue syndrome who are resistant to conventional therapy: a randomized, controlled trial.
    Oka T; Tanahashi T; Chijiwa T; Lkhagvasuren B; Sudo N; Oka K
    Biopsychosoc Med; 2014; 8(1):27. PubMed ID: 25525457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial.
    Cash A; Kaufman DL
    J Transl Med; 2022 Jun; 20(1):295. PubMed ID: 35764955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender-specific changes in the microRNA expression profiling in ME/CFS.
    Cheema AK; Sarria L; Bekheit M; Collado F; Almenar-Pérez E; Martín-Martínez E; Alegre J; Castro-Marrero J; Fletcher MA; Klimas NG; Oltra E; Nathanson L
    J Cell Mol Med; 2020 May; 24(10):5865-5877. PubMed ID: 32291908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME).
    Petty RD; McCarthy NE; Le Dieu R; Kerr JR
    PLoS One; 2016; 11(3):e0150904. PubMed ID: 26967895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.
    Brenu EW; Ashton KJ; Batovska J; Staines DR; Marshall-Gradisnik SM
    PLoS One; 2014; 9(9):e102783. PubMed ID: 25238588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D status in chronic fatigue syndrome/myalgic encephalomyelitis: a cohort study from the North-West of England.
    Earl KE; Sakellariou GK; Sinclair M; Fenech M; Croden F; Owens DJ; Tang J; Miller A; Lawton C; Dye L; Close GL; Fraser WD; McArdle A; Beadsworth MBJ
    BMJ Open; 2017 Nov; 7(11):e015296. PubMed ID: 29118054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Review of Mind-Body Interventions to Treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Khanpour Ardestani S; Karkhaneh M; Stein E; Punja S; Junqueira DR; Kuzmyn T; Pearson M; Smith L; Olson K; Vohra S
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34202826
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): protocol for a randomised controlled trial.
    Baos S; Brigden A; Anderson E; Hollingworth W; Price S; Mills N; Beasant L; Gaunt D; Garfield K; Metcalfe C; Parslow R; Downing H; Kessler D; Macleod J; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Crawley E
    Trials; 2018 Feb; 19(1):136. PubMed ID: 29471861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruiting Adolescents With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis to Internet-Delivered Therapy: Internal Pilot Within a Randomized Controlled Trial.
    Anderson E; Parslow R; Hollingworth W; Mills N; Beasant L; Gaunt D; Metcalfe C; Kessler D; Macleod J; Pywell S; Pitts K; Price S; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Crawley E
    J Med Internet Res; 2020 Aug; 22(8):e17768. PubMed ID: 32784188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis.
    Escorihuela RM; Capdevila L; Castro JR; Zaragozà MC; Maurel S; Alegre J; Castro-Marrero J
    J Transl Med; 2020 Jan; 18(1):4. PubMed ID: 31906988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
    Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR
    J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
    Eaton N; Cabanas H; Balinas C; Klein A; Staines D; Marshall-Gradisnik S
    BMC Pharmacol Toxicol; 2018 Mar; 19(1):12. PubMed ID: 29587879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Results From Open-Label Cyclophosphamide Intervention Study.
    Sørland K; Sandvik MK; Rekeland IG; Ribu L; Småstuen MC; Mella O; Fluge Ø
    Front Med (Lausanne); 2021; 8():642710. PubMed ID: 33829023
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study.
    Castro-Marrero J; Serrano-Pertierra E; Oliveira-Rodríguez M; Zaragozá MC; Martínez-Martínez A; Blanco-López MDC; Alegre J
    J Extracell Vesicles; 2018; 7(1):1453730. PubMed ID: 29696075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    van Campen CLMC; Rowe PC; Verheugt FWA; Visser FC
    Front Med (Lausanne); 2020; 7():602894. PubMed ID: 33585505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.